Alberto Verrottı

2.0k total citations · 1 hit paper
52 papers, 977 citations indexed

About

Alberto Verrottı is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alberto Verrottı has authored 52 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 19 papers in Pediatrics, Perinatology and Child Health and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alberto Verrottı's work include Epilepsy research and treatment (22 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Neuroscience and Neuropharmacology Research (13 papers). Alberto Verrottı is often cited by papers focused on Epilepsy research and treatment (22 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Neuroscience and Neuropharmacology Research (13 papers). Alberto Verrottı collaborates with scholars based in Italy, United States and Germany. Alberto Verrottı's co-authors include Pasquale Striano, Sara Matricardi, Giuseppe Di Cara, Grazia Maria Giovanna Pastorino, Francesca Felicia Operto, Giovanni Battista Dell’Isola, Giulia Iapadre, Elisabetta Mencaroni, Marco Carotenuto and Luca Zagaroli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and International Journal of Environmental Research and Public Health.

In The Last Decade

Alberto Verrottı

52 papers receiving 951 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies

2021 156 citations Antonella Fattorusso, Sara Matricardi et al. Frontiers in Neurology profile →

Peers

Countries citing papers authored by Alberto Verrottı

Since Specialization

Citations

This map shows the geographic impact of Alberto Verrottı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Verrottı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Verrottı more than expected).

Fields of papers citing papers by Alberto Verrottı

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Verrottı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Verrottı. The network helps show where Alberto Verrottı may publish in the future.

Co-authorship network of co-authors of Alberto Verrottı

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Verrottı. A scholar is included among the top collaborators of Alberto Verrottı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Verrottı. Alberto Verrottı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine 2022 ·Frontiers in Pharmacology ·(unknown), (unknown), Giovanni Battista Dell’Isola, Elisabetta Mencaroni, Giuseppe Di Cara, Pasquale Striano, Alberto Verrottı	8
2	Acute Neurological Presentation in Children With SARS-CoV-2 Infection 2022 ·Frontiers in Pediatrics ·Antonella Riva, Gianluca Piccolo, (unknown), (unknown), Noemi Brolatti, Alberto Verrottı, Elisabetta Amadori, Alberto Spalice, Thea Giacomini, Maria Margherita Mancardi, Paola Iannetti, Maria Stella Vari, Emanuela Piccotti, Pasquale Striano, Giacomo Brisca	6
3	Using the Social Robot NAO for Emotional Support to Children at a Pediatric Emergency Department: Randomized Clinical Trial 2021 ·Journal of Medical Internet Research ·Silvia Rossi, Silvano Junior Santini, (unknown), Gianpaolo Maggi, Alberto Verrottı, Giovanni Farello, (unknown), Anna Alisi, Alberto Eugenio Tozzi, Clara Balsano	21
4	An update on brivaracetam for the treatment of pediatric partial epilepsy 2021 ·Expert Opinion on Pharmacotherapy ·(unknown), Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano, Alberto Verrottı	7
5	Epilepsy in “Sunflower syndrome”: electroclinical features, therapeutic response, and long-term follow-up 2021 ·Seizure ·Vincenzo Belcastro, Susanna Casellato, Pasquale Striano, Giuseppe Capovilla, Salvatore Savasta, Thomas Foiadelli, Vito Sofia, Loretta Giuliano, Antonella Riva, Maurizio Elia, Elisabetta Cesaroni, Carlo Di Bonaventura, (unknown), Salvatore Striano, Antonio Gambardella, Edoardo Ferlazzo, Alberto Verrottı	9
6	The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies breakdown → 2021 ·Frontiers in Neurology ·Antonella Fattorusso, Sara Matricardi, Elisabetta Mencaroni, Giovanni Battista Dell’Isola, Giuseppe Di Cara, Pasquale Striano, Alberto Verrottı	156
7	An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy 2020 ·Cannabis and Cannabinoid Research ·Francesca Marchese, Maria Stella Vari, Ganna Balagura, Antonella Riva, Vincenzo Salpietro, Alberto Verrottı, Rita Citraro, Simona Lattanzi, Carlo Minetti, Emilio Russo, Pasquale Striano	11
8	The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents 2020 ·Frontiers in Pharmacology ·Francesca Felicia Operto, Sara Matricardi, Grazia Maria Giovanna Pastorino, Alberto Verrottı, Giangennaro Coppola	32
9	Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome 2020 ·CNS Drugs ·Ganna Balagura, (unknown), (unknown), Pasquale Striano, Alberto Verrottı	28
10	Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox–Gastaut syndrome: A prospective observational clinical study 2020 ·Epilepsy & Behavior ·Francesca Felicia Operto, Alberto Verrottı, Alfonso Marrelli, (unknown), Giangennaro Coppola, Grazia Maria Giovanna Pastorino, Pasquale Striano, (unknown), Claudio Zucca, Valentina Manfredi, (unknown), Maurizio Elia	16
11	Melkersson–Rosenthal Syndrome in Childhood: Report of Three Paediatric Cases and a Review of the Literature 2019 ·International Journal of Environmental Research and Public Health ·Salvatore Savasta, Alessandra Rossi, Thomas Foiadelli, Amelia Licari, (unknown), Giovanni Farello, Alberto Verrottı, Gian Luigi Marseglia	18
12	Association among nocturnal enuresis, body weight and obstructive sleep apnea in children of south Italy: an observational study 2019 ·PubMed ·Pietro Ferrara, (unknown), Daniele Franco, Giulia Spina, Francesca Ianniello, (unknown), Ottavio Vitelli, (unknown), Alberto Verrottı, Giuseppe Saggese	4
13	Electroclinical features of epilepsy monosomy 1p36 syndrome and their implications 2018 ·Acta Neurologica Scandinavica ·Alberto Verrottı, (unknown), (unknown), (unknown), Salvatore Savasta, Marco Carotenuto, Maurizio Elia, Francesca Felicia Operto, Lucia Margari, Vincenzo Belcastro, Angelo Selicorni, Elena Freri, Sara Matricardi, Tiziana Granata, Francesca Ragona, Giuseppe Capovilla, Alberto Spalice, Giangennaro Coppola, Pasquale Striano	9
14	The impact of motivational therapy in the management of enuretic children 2018 ·SHILAP Revista de lepidopterología ·Pietro Ferrara, (unknown), (unknown), Francesca Ianniello, Alberto Verrottı, Tommasangelo Petitti, Antonio Ruggiero	4
15	Desmopressin 120 mcg, 180 mcg, 240 mcg: The right treatment for the right patient 2018 ·Archivio Italiano di Urologia e Andrologia ·Pietro Ferrara, (unknown), Francesca Ianniello, Giulia Franceschini, (unknown), Alberto Verrottı	3
16	X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel <b><i>EDA</i></b> Gene Mutation 2017 ·Cytogenetic and Genome Research ·Salvatore Savasta, (unknown), Riccardo Castagnoli, Francesca Chiappe, (unknown), (unknown), Vincenzo Salpietro, Valeria Brazzelli, Alberto Verrottı, Gian Luigi Marseglia	8
17	Electroclinical features of epilepsy associated with 1p36 deletion syndrome: A review 2017 ·Epilepsy Research ·(unknown), Pietro Ferrara, Giovanni Farello, Pasquale Striano, Alberto Verrottı	9
18	Polycystic Ovary Syndrome in Adolescence: New Therapeutic Approach with Inositol and Alpha-Lipoic Acid 2016 ·(unknown), (unknown), (unknown), Giovanni Farello, (unknown), Luca Zagaroli, (unknown), Alberto Verrottı	2
19	Plant-Derived and Endogenous Cannabinoids in Epilepsy 2016 ·Clinical Drug Investigation ·Alberto Verrottı, (unknown), Mauro Maccarrone, Filomena Fezza	15
20	Enuresis and Punishment: The Adverse Effects on Child Development and on Treatment 2016 ·Urologia Internationalis ·Pietro Ferrara, (unknown), (unknown), (unknown), (unknown), Costanza Cutrona, Alberto Verrottı	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact